Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hi-Tech Pharmacal third-quarter revenues up 18% with "strong" sales from branded OTCs.

This article was originally published in The Tan Sheet

Executive Summary

HI-TECH PHARMACAL THIRD-QUARTER SALES RISE 18% to $4.7 mil. for the period ended Jan. 31. The company attributed the increase to "strong sales" by its Health Care Products division and a contribution from Rose Labs, which was acquired in November 1994. The Health Care division sells company-brand OTCs under the H-T, Sooth-It and Diabetic Tussin brands. Rose Labs manufactures private-label suppository products ("The Tan Sheet" Nov. 7, 1994, In Brief)
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083804

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel